Updated Jul 16, 2026
Laponis Adam has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.42M.

Adam Laponis is the Chief Financial Officer of Twist Bioscience Corp, a company specializing in synthetic biology and DNA synthesis. He has been involved in various SEC filings related to the company's financial activities.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | TWST | Twist Bioscience Corp | S — Open-market sale | 2.4K | $94.33 | $226K |
| 2026-06-02 | TWST | Twist Bioscience Corp | S — Open-market sale | 4.0K | $70.00 | $280K |
| 2026-05-26 | TWST | Twist Bioscience Corp | S — Open-market sale | 2.0K | $53.26 | $108K |
| 2026-04-21 | TWST | Twist Bioscience Corp | S — Open-market sale | 4.0K | $60.00 | $240K |
| 2026-04-16 | TWST | Twist Bioscience Corp | S — Open-market sale | 3.0K | $55.00 | $165K |
| 2026-04-13 | TWST | Twist Bioscience Corp | S — Open-market sale | 2.6K | $49.89 | $130K |
| 2026-02-25 | TWST | Twist Bioscience Corp | S — Open-market sale | 2.1K | $46.71 | $97K |
| 2026-02-13 | TWST | Twist Bioscience Corp | S — Open-market sale [10b5-1] | 7.0K | $50.00 | $350K |
| 2026-01-15 | TWST | Twist Bioscience Corp | S — Open-market sale [10b5-1] | 3.0K | $40.00 | $120K |
| 2025-10-08 | TWST | Twist Bioscience Corp | S — Open-market sale | 2.5K | $32.92 | $83K |
| 2025-10-08 | TWST | Twist Bioscience Corp | S — Open-market sale | 3.0K | $31.15 | $93K |
| 2025-10-06 | TWST | Twist Bioscience Corp | S — Open-market sale | 5.9K | $32.19 | $189K |
| 2025-08-21 | TWST | Twist Bioscience Corp | S — Open-market sale | 918 | $25.96 | $24K |
| 2025-07-09 | TWST | Twist Bioscience Corp | S — Open-market sale | 2.4K | $38.15 | $93K |
| 2024-12-06 | TWST | Twist Bioscience Corp | A — Grant or award | 26.7K | $0.00 | |
| 2024-11-08 | TWST | Twist Bioscience Corp | S — Open-market sale | 4.2K | $44.60 | $186K |
| 2024-11-06 | TWST | Twist Bioscience Corp | A — Grant or award | 20.0K | $0.00 | |
| 2024-10-11 | TWST | Twist Bioscience Corp | S — Open-market sale | 856 | $41.81 | $36K |
Adam Laponis is the Chief Financial Officer of Twist Bioscience Corp, a company specializing in synthetic biology and DNA synthesis. He has been involved in various SEC filings related to the company's financial activities.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 16 open-market sales ($2.42M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Laponis Adam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.